177 related articles for article (PubMed ID: 7679061)
1. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).
Mollnes TE; Redl H; Høgåsen K; Bengtsson A; Garred P; Speilberg L; Lea T; Oppermann M; Götze O; Schlag G
Clin Exp Immunol; 1993 Feb; 91(2):295-300. PubMed ID: 7679061
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulin treatment activates complement in vivo.
Mollnes TE; Høgåsen K; De Carolis C; Vaquero E; Nielsen EW; Fontana L; Perricone R
Scand J Immunol; 1998 Sep; 48(3):312-7. PubMed ID: 9743219
[TBL] [Abstract][Full Text] [Related]
4. Complement and leukocyte activation in septic baboons.
Bengtsson A; Redl H; Paul E; Schlag G; Mollnes TE; Davies J
Circ Shock; 1993 Feb; 39(2):83-8. PubMed ID: 8490996
[TBL] [Abstract][Full Text] [Related]
5. Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3.
Palarasah Y; Skjodt K; Brandt J; Teisner B; Koch C; Vitved L; Skjoedt MO
J Immunol Methods; 2010 Oct; 362(1-2):142-50. PubMed ID: 20869965
[TBL] [Abstract][Full Text] [Related]
6. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
7. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3.
Garred P; Mollnes TE; Lea T
Scand J Immunol; 1988 Mar; 27(3):329-35. PubMed ID: 2451274
[TBL] [Abstract][Full Text] [Related]
8. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.
Kabut J; Kondera-Anasz Z; Sikora J; Mielczarek-Palacz A
Fertil Steril; 2007 Nov; 88(5):1298-303. PubMed ID: 17482181
[TBL] [Abstract][Full Text] [Related]
9. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
[TBL] [Abstract][Full Text] [Related]
10. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of soluble C3 and C9 neoepitopes by human alveolar macrophages in vitro.
Pettersen HB; Johnson E; Mollnes TE; Garred P
Scand J Immunol; 1988 Oct; 28(4):431-4. PubMed ID: 2461585
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
Vachino G; Gelfand JA; Atkins MB; Tamerius JD; Demchak P; Mier JW
Blood; 1991 Nov; 78(10):2505-13. PubMed ID: 1824247
[TBL] [Abstract][Full Text] [Related]
13. Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury.
Kotimaa JP; van Werkhoven MB; O'Flynn J; Klar-Mohamad N; van Groningen J; Schilders G; Rutjes H; Daha MR; Seelen MA; van Kooten C
J Immunol Methods; 2015 Apr; 419():25-34. PubMed ID: 25733354
[TBL] [Abstract][Full Text] [Related]
14. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
Kusunoki Y
Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria is accompanied by intratubular complement activation and apical membrane deposition of C3dg and C5b-9 in kidney transplant recipients.
Isaksson GL; Nielsen MB; Hinrichs GR; Krogstrup NV; Zachar R; Stubmark H; Svenningsen P; Madsen K; Bistrup C; Jespersen B; Birn H; Palarasah Y; Jensen BL;
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F150-F163. PubMed ID: 34927448
[TBL] [Abstract][Full Text] [Related]
16. Complement activation in relation to development of preeclampsia.
Haeger M; Unander M; Bengtsson A
Obstet Gynecol; 1991 Jul; 78(1):46-9. PubMed ID: 2047067
[TBL] [Abstract][Full Text] [Related]
17. The release of C5a in complement-activated serum does not require C6.
Biesecker G; Wagner JL; Hugli TE
J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
[TBL] [Abstract][Full Text] [Related]
18. Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut.
Rønholm E; Tomasdottir H; Runeborg J; Bengtsson A; Bengtson JP; Stenqvist O; Friman S
Transplantation; 1994 Jun; 57(11):1594-7. PubMed ID: 8009593
[TBL] [Abstract][Full Text] [Related]
19. The severity of clinical symptoms in ragweed-allergic patients is related to the extent of ragweed-induced complement activation in their sera.
Gönczi Z; Varga L; Hidvégi T; Schmidt B; Pánya A; Kókai M; Füst G
Allergy; 1997 Nov; 52(11):1110-4. PubMed ID: 9404564
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
